Surgical Management of Pancreatic Neuroendocrine Tumors

por Sulciner, Megan L., Clancy, Thomas E.
Publicado 2023

Resolution medicine in cancer, infection, pain and inflammation: are we on track to address the next Pandemic?

por Serhan, Charles N., Sulciner, Megan L.
Publicado 2023

Advances and Remaining Challenges in the Treatment for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

por Sulciner, Megan L., Ashley, Stanley W., Molina, George
Publicado 2022

Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study

por Kjaer, Josefine, Clancy, Thomas E., Thornell, Anders, Andersson, Niklas, Hellman, Per, Crona, Joakim, Welin, Staffan, Sulciner, Megan, Powell, Brittany, Brais, Lauren, Astone, Kristina, Baddoo, William, Doherty, Gerhard, Chan, Jennifer A., Norlén, Olov, Stålberg, Peter
Publicado 2022

Resolvins suppress tumor growth and enhance cancer therapy

por Sulciner, Megan L., Serhan, Charles N., Gilligan, Molly M., Mudge, Dayna K., Chang, Jaimie, Gartung, Allison, Lehner, Kristen A., Bielenberg, Diane R., Schmidt, Birgitta, Dalli, Jesmond, Greene, Emily R., Gus-Brautbar, Yael, Piwowarski, Julia, Mammoto, Tadanori, Zurakowski, David, Perretti, Mauro, Sukhatme, Vikas P., Kaipainen, Arja, Kieran, Mark W., Huang, Sui, Panigrahy, Dipak
Publicado 2018